CLINICAL_TRIALS
withdrawal
· 2016-04-27
Clinical Trial Update: A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma [Phase 3]
Summary
A Phase 3 trial comparing transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) for unilobar advanced hepatocellular carcinoma has b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: WITHDRAWN